JAMA Pediatr:婴儿体重的增加与1型糖尿病呈正相关

2015-12-30 徐媛 MedSci原创

在婴儿和儿童成长过程中,1型糖尿病是最常见的慢性疾病之一,但由于环境风险因素引发的糖尿病尚未有令人信服的证据。本研究旨在评估在婴儿出生后第1年的成长过程中是否会增加儿童1型糖尿病的发病风险。 本研究以以挪威和丹麦人群为基础进行两项队列研究,分别为挪威出生儿童队列研究(MoBa)和丹麦国家出生儿童队列(DNBC),儿童出生时间在1998年2月到1998年7月。观察指标为从出生到1岁儿童体重和身长的

在婴儿和儿童成长过程中,1型糖尿病是最常见的慢性疾病之一,但由于环境风险因素引发的糖尿病尚未有令人信服的证据。本研究旨在评估在婴儿出生后第1年的成长过程中是否会增加儿童1型糖尿病的发病风险。

本研究以以挪威和丹麦人群为基础进行两项队列研究,分别为挪威出生儿童队列研究(MoBa)和丹麦国家出生儿童队列(DNBC),儿童出生时间在1998年2月到1998年7月。观察指标为从出生到1岁儿童体重和身长的变化。利用Cox比例风险回归计算1型糖尿病校正和未校正危险比(HR),评估出生后第1年的身高和体重与儿童期1型糖尿病的相关性。

研究人员收纳了99832名儿童,其中MoBa研究包含22159名儿童 (51.2%男孩和48.8%女孩,在随访,平均年龄8.6岁(范围4.6-14.2岁),在DNBC研究中有40611名儿童(50.6%男孩和49.4%女孩,在随访,平均年龄13.0岁(范围10.4 -15.7岁)。

来自的挪威和丹麦儿童队列从1岁至随访结束,1型糖尿病的发病率分别为31/10万(人/年)和25/10万(人/年)。出生至12个月时的体重变化与1型糖尿病发病呈正相关(每升高1个标准差,未校正HR为1.24,95% CI, 1.11-1.39; 每升高1个标准差,校正后HR=1.24 ; 95% CI, 1.09-1.41))。从出生到1岁身长与1型糖尿病的发病率没有明显关联(每升高1个标准差,为校正HR=1.06; 95% CI, 0.93-1.22; 每升高1个标准差,校正后HR=1.06; 95% CI, 0.86-1.32)。男女相关性相似。

以上研究结果表明,出生后第1年的婴儿体重增加与1型糖尿病存在相关性。

原始出处

Magnus MC1, Olsen SF2, Granstr?m C2, Joner G3, Skrivarhaug T4, Svensson J5, Johannesen J5, Nj?lstad P6, Magnus P7, St?rdal K8, Stene LC1JAMA+Pediatr+2015%EF%BC%8C169(12)%EF%BC%9Ae153759">.Infant Growth and Risk of Childhood-Onset Type 1 Diabetes in Children From 2 Scandinavian Birth Cohorts.JAMA Pediatr. 2015 Dec 7

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1725981, encodeId=1ca01e259817e, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Thu Jun 23 10:29:00 CST 2016, time=2016-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1637243, encodeId=2ff0163e24321, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Thu Jun 09 19:29:00 CST 2016, time=2016-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1994506, encodeId=acf419945065d, content=<a href='/topic/show?id=84326326141' target=_blank style='color:#2F92EE;'>#正相关#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63261, encryptionId=84326326141, topicName=正相关)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=742793, createdName=zutt, createdTime=Sun Mar 06 13:29:00 CST 2016, time=2016-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=59052, encodeId=fe90590527d, content=不是遗传病吗, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK29w9r0upRgxUXHNhe7bd3VxHnhBSpibMbKOjtX92zXr78SkuZfUNuADrjHiaw6uibZaEYjh9cJLzew/132, createdBy=261e1682638, createdName=1de3b290m83(暂无匿称), createdTime=Sun Jan 24 18:35:00 CST 2016, time=2016-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=52716, encodeId=255752e1620, content=好大的样本量,学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=77e41648823, createdName=miaotao, createdTime=Thu Jan 07 14:05:00 CST 2016, time=2016-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=50378, encodeId=2e8c503e80b, content=赞一个, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fe261399236, createdName=xyfg98, createdTime=Wed Dec 30 10:38:00 CST 2015, time=2015-12-30, status=1, ipAttribution=)]
    2016-06-23 feather89
  2. [GetPortalCommentsPageByObjectIdResponse(id=1725981, encodeId=1ca01e259817e, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Thu Jun 23 10:29:00 CST 2016, time=2016-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1637243, encodeId=2ff0163e24321, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Thu Jun 09 19:29:00 CST 2016, time=2016-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1994506, encodeId=acf419945065d, content=<a href='/topic/show?id=84326326141' target=_blank style='color:#2F92EE;'>#正相关#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63261, encryptionId=84326326141, topicName=正相关)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=742793, createdName=zutt, createdTime=Sun Mar 06 13:29:00 CST 2016, time=2016-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=59052, encodeId=fe90590527d, content=不是遗传病吗, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK29w9r0upRgxUXHNhe7bd3VxHnhBSpibMbKOjtX92zXr78SkuZfUNuADrjHiaw6uibZaEYjh9cJLzew/132, createdBy=261e1682638, createdName=1de3b290m83(暂无匿称), createdTime=Sun Jan 24 18:35:00 CST 2016, time=2016-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=52716, encodeId=255752e1620, content=好大的样本量,学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=77e41648823, createdName=miaotao, createdTime=Thu Jan 07 14:05:00 CST 2016, time=2016-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=50378, encodeId=2e8c503e80b, content=赞一个, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fe261399236, createdName=xyfg98, createdTime=Wed Dec 30 10:38:00 CST 2015, time=2015-12-30, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1725981, encodeId=1ca01e259817e, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Thu Jun 23 10:29:00 CST 2016, time=2016-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1637243, encodeId=2ff0163e24321, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Thu Jun 09 19:29:00 CST 2016, time=2016-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1994506, encodeId=acf419945065d, content=<a href='/topic/show?id=84326326141' target=_blank style='color:#2F92EE;'>#正相关#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63261, encryptionId=84326326141, topicName=正相关)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=742793, createdName=zutt, createdTime=Sun Mar 06 13:29:00 CST 2016, time=2016-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=59052, encodeId=fe90590527d, content=不是遗传病吗, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK29w9r0upRgxUXHNhe7bd3VxHnhBSpibMbKOjtX92zXr78SkuZfUNuADrjHiaw6uibZaEYjh9cJLzew/132, createdBy=261e1682638, createdName=1de3b290m83(暂无匿称), createdTime=Sun Jan 24 18:35:00 CST 2016, time=2016-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=52716, encodeId=255752e1620, content=好大的样本量,学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=77e41648823, createdName=miaotao, createdTime=Thu Jan 07 14:05:00 CST 2016, time=2016-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=50378, encodeId=2e8c503e80b, content=赞一个, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fe261399236, createdName=xyfg98, createdTime=Wed Dec 30 10:38:00 CST 2015, time=2015-12-30, status=1, ipAttribution=)]
    2016-03-06 zutt
  4. [GetPortalCommentsPageByObjectIdResponse(id=1725981, encodeId=1ca01e259817e, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Thu Jun 23 10:29:00 CST 2016, time=2016-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1637243, encodeId=2ff0163e24321, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Thu Jun 09 19:29:00 CST 2016, time=2016-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1994506, encodeId=acf419945065d, content=<a href='/topic/show?id=84326326141' target=_blank style='color:#2F92EE;'>#正相关#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63261, encryptionId=84326326141, topicName=正相关)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=742793, createdName=zutt, createdTime=Sun Mar 06 13:29:00 CST 2016, time=2016-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=59052, encodeId=fe90590527d, content=不是遗传病吗, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK29w9r0upRgxUXHNhe7bd3VxHnhBSpibMbKOjtX92zXr78SkuZfUNuADrjHiaw6uibZaEYjh9cJLzew/132, createdBy=261e1682638, createdName=1de3b290m83(暂无匿称), createdTime=Sun Jan 24 18:35:00 CST 2016, time=2016-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=52716, encodeId=255752e1620, content=好大的样本量,学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=77e41648823, createdName=miaotao, createdTime=Thu Jan 07 14:05:00 CST 2016, time=2016-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=50378, encodeId=2e8c503e80b, content=赞一个, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fe261399236, createdName=xyfg98, createdTime=Wed Dec 30 10:38:00 CST 2015, time=2015-12-30, status=1, ipAttribution=)]
    2016-01-24 1de3b290m83(暂无匿称)

    不是遗传病吗

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1725981, encodeId=1ca01e259817e, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Thu Jun 23 10:29:00 CST 2016, time=2016-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1637243, encodeId=2ff0163e24321, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Thu Jun 09 19:29:00 CST 2016, time=2016-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1994506, encodeId=acf419945065d, content=<a href='/topic/show?id=84326326141' target=_blank style='color:#2F92EE;'>#正相关#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63261, encryptionId=84326326141, topicName=正相关)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=742793, createdName=zutt, createdTime=Sun Mar 06 13:29:00 CST 2016, time=2016-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=59052, encodeId=fe90590527d, content=不是遗传病吗, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK29w9r0upRgxUXHNhe7bd3VxHnhBSpibMbKOjtX92zXr78SkuZfUNuADrjHiaw6uibZaEYjh9cJLzew/132, createdBy=261e1682638, createdName=1de3b290m83(暂无匿称), createdTime=Sun Jan 24 18:35:00 CST 2016, time=2016-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=52716, encodeId=255752e1620, content=好大的样本量,学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=77e41648823, createdName=miaotao, createdTime=Thu Jan 07 14:05:00 CST 2016, time=2016-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=50378, encodeId=2e8c503e80b, content=赞一个, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fe261399236, createdName=xyfg98, createdTime=Wed Dec 30 10:38:00 CST 2015, time=2015-12-30, status=1, ipAttribution=)]
    2016-01-07 miaotao

    好大的样本量,学习

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1725981, encodeId=1ca01e259817e, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Thu Jun 23 10:29:00 CST 2016, time=2016-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1637243, encodeId=2ff0163e24321, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Thu Jun 09 19:29:00 CST 2016, time=2016-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1994506, encodeId=acf419945065d, content=<a href='/topic/show?id=84326326141' target=_blank style='color:#2F92EE;'>#正相关#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63261, encryptionId=84326326141, topicName=正相关)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=742793, createdName=zutt, createdTime=Sun Mar 06 13:29:00 CST 2016, time=2016-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=59052, encodeId=fe90590527d, content=不是遗传病吗, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK29w9r0upRgxUXHNhe7bd3VxHnhBSpibMbKOjtX92zXr78SkuZfUNuADrjHiaw6uibZaEYjh9cJLzew/132, createdBy=261e1682638, createdName=1de3b290m83(暂无匿称), createdTime=Sun Jan 24 18:35:00 CST 2016, time=2016-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=52716, encodeId=255752e1620, content=好大的样本量,学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=77e41648823, createdName=miaotao, createdTime=Thu Jan 07 14:05:00 CST 2016, time=2016-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=50378, encodeId=2e8c503e80b, content=赞一个, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fe261399236, createdName=xyfg98, createdTime=Wed Dec 30 10:38:00 CST 2015, time=2015-12-30, status=1, ipAttribution=)]
    2015-12-30 xyfg98

    赞一个

    0

相关资讯

Cell Stem Cell :1型糖尿病患者为何会出现胃肠道症状?

Cell Stem Cell :1型糖尿病患者为何会出现胃肠道症状?据10月1日发表于 Cell Stem Cell的一项研究揭示了80%的1型糖尿病患者会出现慢性胃肠道症状,包括胃轻瘫(包括胃排空延迟),肠易激惹综合征,腹胀,大便失禁,的分子机制。这些症状统称为糖尿病肠病,严重影响了1型糖尿病患者的生活质量,其发病机制却尚未可知。该研究的共同第一作者为Franco Folli博士,来自德克萨斯

BMJ新闻:儿童出生后第1年的体重增加与日后1型糖尿病的发生有关

据发表于JAMA Pediatric的一项研究表明,儿童出生后1年的体重变化与其日后1型糖尿病的发生之间存在正相关关系。

JAMA:1型糖尿病患者使用胰岛素联合二甲双胍并不能有效控制血糖

研究者进行了一项研究,探究对于1型糖尿病超重青少年,在胰岛素的基础上添加二甲双胍对其血糖控制的有效性和安全性。该多中心、双盲、安慰剂对照的随机临床试验纳入了12.1-19.6岁 (mean [SD] 15.3 [1.7]岁) 的140名1型糖尿病(患病时长 7.0 (3.3))青少年,平均BMI位于94百分位,平均每日胰岛素使用为 1.1 (0.2) U/kg,平均HbA1c为8.8% (0.7%

Lancet Dia & Endo:1型糖尿病患者心脏衰竭的风险增加

糖尿病是心脏衰竭的危险因素,但由于几乎所有的心脏衰竭发生于老年个体,所以1型糖尿病的个体的心脏衰竭多余的风险和危险因素是未知的。该研究的目的是确定在1型糖尿病患者的总体和不同程度的蛋白尿患者血糖控制的患者心脏衰竭的风险。在这项前瞻性病例对照研究中,研究人员确定了所有1998年1月1日和2011年12月31日在瑞典全国糖尿病登记处注册的1型糖尿病患者,并从5个队列中随机抽取为每一位患者的对照,根据年

CDS 2015:滕卫平:1型糖尿病表观遗传学研究进展

1型糖尿病(T1DM)是遗传背景与环境因素共同作用下发生的复杂疾病,易感基因的携带是T1DM重要的危险因素,但遗传因素并不能解释T1DM全部病因。在DNA序列之外,存在可以稳定遗传的对基因表达的调控,称为表观遗传学。表观遗传学主要的修饰方式包括DNA甲基化、组蛋白转录后修饰和非编码RNA修饰。DNA甲基化的主要生物功能是抑制转录,去甲基化的中间过程——羟甲基化的生物学功能是促进转录。组蛋白修饰包括

Lancet Dia & Endo:1型糖尿病患者:人工胰脏安全又好用

人工胰脏(AP),可以在家里从晚餐到早晨醒来时戴在身上,这对于1型糖尿病患者患者首次常规使用是安全和有效的。研究人员评估了白天使用传感器增强型胰岛素泵治疗(SAP)的患者在晚上和夜间使用AP血糖控制的效果,并与24小时只使用SAP的患者进行了比较,患者都是在自由生活条件下完成。研究人员在法国,意大利和荷兰的医疗中心做了一个交叉研究,参与者为1型糖尿病使用胰岛素泵持续皮下胰岛素输注的患者,年龄在18